BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders

被引:76
作者
Rodig, SJ
Shahsafaei, A
Li, B
Mackay, CR
Dorfman, DM
机构
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Garvan Inst Med Res, Arthritis & Inflammat Program, Darlinghurst, NSW 2010, Australia
关键词
non-Hodgkin lymphoma; immunohistochemistry; flow cytometry; T cells;
D O I
10.1016/j.humpath.2005.08.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
B cell-activating factor receptor (BAFF-R) is one of three known receptors for BAFF, a critical regulator of B- and T-cell function. In mice, BAFF-R is required for B-cell maturation and survival, and in mice and humans, the overproduction of BAFF is associated with autoimmune disease. We sought to determine the normal pattern of BAFF-R expression at specific stages of B- and T-cell development and whether this pattern of expression corresponds with related B- and T-cell neoplasms. Most circulating human B cells and a small subset of T cells are BAFF-R-positive. In reactive lymphoid tissues, BAFF-R is expressed by B cells colonizing the mantle zones, by a subset of cells within germinal centers, and rare cells in the interfollicular T-cell zone. BAFF-R is also expressed by B cells colonizing the splenic marginal zone. Seventy-seven (78%) of 116 cases of B-cell lymphoproliterative disorders were BAFF-R-positive by immunohistochemical and/or flow cytometric immunophenotypic analysis, including most cases of mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, chronic lymphocytic leukemia, hairy cell leukemia, and diffuse large B-cell lymphoma. In contrast, cases of precursor B lymphoblastic lymphoma, Burkitt lymphoma, and nodular lymphocyte-predominant Hodgkin lymphoma exhibit weak to negative staining for BAFF-R. All cases of classical Hodgkin lymphoma and T-cell lymphomas were BAFF-R-negative, including all cases of anaplastic large cell lymphoma, adult T-cell leukemia/lymphoma, angioimmunoblastic T-cell lymphoma, and peripheral T-cell lymphoma, unspecified. These findings highlight BAFF-R as a marker of both normal and neoplastic B cells and raise the possibility that BAFF-R expression is necessary for the survival of a subset of neoplastic B lymphocytes analogous to its known role in promoting normal B-cell maturation and survival. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1113 / 1119
页数:7
相关论文
共 22 条
[1]   TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma [J].
Batten, M ;
Fletcher, C ;
Ng, LG ;
Groom, J ;
Wheway, J ;
Laâbi, Y ;
Xin, XG ;
Schneider, P ;
Tschopp, J ;
Mackay, CR ;
Mackay, F .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :812-822
[2]   TACI and BAFF-R mediate isotype switching in B cells [J].
Castigli, E ;
Wilson, SA ;
Scott, S ;
Dedeoglu, F ;
Xu, SL ;
Lam, KP ;
Bram, RJ ;
Jabara, H ;
Geha, RS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (01) :35-39
[3]   ANALYSIS OF MUTATIONS IN IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE REGION GENES OF MICRODISSECTED MARGINAL ZONE (MGZ) B-CELLS SUGGESTS THAT THE MGZ OF HUMAN SPLEEN IS A RESERVOIR OF MEMORY B-CELLS [J].
DUNNWALTERS, DK ;
ISAACSON, PG ;
SPENCER, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) :559-566
[4]   The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
MODERN PATHOLOGY, 2000, 13 (02) :193-207
[5]   Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations [J].
Mackay, F ;
Woodcock, SA ;
Lawton, P ;
Ambrose, C ;
Baetscher, M ;
Schneider, P ;
Tschopp, J ;
Browning, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) :1697-1710
[6]   BAFF: A fundamental survival factor for B cells [J].
Mackay, F ;
Browning, JL .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (07) :465-475
[7]   BAFF and APRIL: A tutorial on B cell survival [J].
Mackay, F ;
Schneider, P ;
Rennert, P ;
Browning, J .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :231-264
[8]  
Mackay Fabienne, 2005, V8, P243
[9]   Regulation of B-cell survival by BAFF-dependent PKCδ-mediated nuclear signalling [J].
Mecklenbräuker, I ;
Kalled, SL ;
Leitges, M ;
Mackay, F ;
Tarakhovsky, A .
NATURE, 2004, 431 (7007) :456-461
[10]  
Melchers F, 2003, ANN RHEUM DIS, V62, P25